Comments
Loading...
Cartesian Therapeutics Rapporto sugli interessi allo scoperto
RNACNASDAQ
Report sulle vendite allo scoperto
Il short interest su Cartesian Therapeutics Inc (NASDAQ:RNAC) è diminuito durante l'ultimo periodo di rilevazione, aumentando da 2.33M a 2.24M. Questo rappresenta il 21.69% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in Cartesian Therapeutics Corp (XNAS:RNAC) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 96.01K azioni scambiate al giorno, ci vorrebbero 23.38 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
2.24M
Vendite allo scoperto %
21.7%
Giorni di copertura
23.38
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
RNAC | Cartesian Therapeutics, Inc. C | 09/30/2025 | 10/09/2025 | 21.69% | 10,348,881 | 2,244,672 | 96,012 | 23.38 | |
RNAC | Cartesian Therapeutics, Inc. C | 09/15/2025 | 09/24/2025 | 22.53% | 10,348,881 | 2,331,102 | 52,354 | 44.53 | |
RNAC | Cartesian Therapeutics, Inc. C | 08/29/2025 | 09/10/2025 | 22.85% | 10,348,881 | 2,364,831 | 52,056 | 45.43 | |
RNAC | Cartesian Therapeutics, Inc. C | 08/15/2025 | 08/26/2025 | 22.88% | 10,348,881 | 2,367,515 | 46,316 | 51.12 | |
RNAC | Cartesian Therapeutics, Inc. C | 07/31/2025 | 08/11/2025 | 23.60% | 10,348,881 | 2,442,330 | 61,536 | 39.69 | |
RNAC | Cartesian Therapeutics, Inc. C | 07/15/2025 | 07/24/2025 | 25.23% | 10,301,130 | 2,599,153 | 82,757 | 31.41 | |
RNAC | Cartesian Therapeutics, Inc. C | 06/30/2025 | 07/10/2025 | 24.86% | 10,301,130 | 2,561,225 | 78,874 | 32.47 | |
RNAC | Cartesian Therapeutics, Inc. C | 06/13/2025 | 06/25/2025 | 25.51% | 10,301,130 | 2,627,712 | 65,664 | 40.02 | |
RNAC | Cartesian Therapeutics, Inc. C | 05/30/2025 | 06/10/2025 | 24.77% | 10,301,130 | 2,551,444 | 62,274 | 40.97 | |
RNAC | Cartesian Therapeutics, Inc. C | 05/15/2025 | 05/27/2025 | 24.33% | 10,301,130 | 2,506,042 | 87,262 | 28.72 | |
RNAC | Cartesian Therapeutics, Inc. C | 04/30/2025 | 05/09/2025 | 15.41% | 16,449,283 | 2,534,226 | 69,138 | 36.65 | |
RNAC | Cartesian Therapeutics, Inc. C | 04/15/2025 | 04/25/2025 | 14.49% | 16,449,283 | 2,383,018 | 162,762 | 14.64 | |
RNAC | Cartesian Therapeutics, Inc. C | 03/31/2025 | 04/09/2025 | 12.75% | 16,449,283 | 2,097,191 | 103,188 | 20.32 | |
RNAC | Cartesian Therapeutics, Inc. C | 03/14/2025 | 03/25/2025 | 12.34% | 16,449,283 | 2,030,051 | 89,343 | 22.72 | |
RNAC | Cartesian Therapeutics, Inc. C | 02/28/2025 | 03/11/2025 | 12.92% | 16,267,488 | 2,101,196 | 69,762 | 30.12 | |
RNAC | Cartesian Therapeutics, Inc. C | 02/14/2025 | 02/26/2025 | 12.43% | 16,267,488 | 2,022,042 | 52,131 | 38.79 | |
RNAC | Cartesian Therapeutics, Inc. C | 01/31/2025 | 02/11/2025 | 12.11% | 16,267,488 | 1,969,856 | 70,021 | 28.13 | |
RNAC | Cartesian Therapeutics, Inc. C | 01/15/2025 | 01/27/2025 | 12.35% | 16,267,488 | 2,008,843 | 110,341 | 18.21 | |
RNAC | Cartesian Therapeutics, Inc. C | 12/31/2024 | 01/10/2025 | 12.57% | 15,957,080 | 2,006,013 | 162,687 | 12.33 | |
RNAC | Cartesian Therapeutics, Inc. C | 12/13/2024 | 12/24/2024 | 11.26% | 15,957,080 | 1,796,563 | 144,967 | 12.39 | |
RNAC | Cartesian Therapeutics, Inc. C | 11/29/2024 | 12/10/2024 | 11.47% | 15,957,080 | 1,830,389 | 96,571 | 18.95 | |
RNAC | Cartesian Therapeutics, Inc. C | 11/15/2024 | 11/26/2024 | 11.65% | 15,957,080 | 1,859,311 | 132,838 | 14 | |
RNAC | Cartesian Therapeutics, Inc. C | 10/31/2024 | 11/11/2024 | 13.35% | 14,438,707 | 1,928,027 | 68,723 | 28.06 | |
RNAC | Cartesian Therapeutics, Inc. C | 10/15/2024 | 10/24/2024 | 13.47% | 14,438,707 | 1,944,921 | 168,675 | 11.53 | |
RNAC | Cartesian Therapeutics, Inc. C | 09/30/2024 | 10/09/2024 | 17.24% | 11,929,731 | 2,056,590 | 79,916 | 25.73 | |
RNAC | Cartesian Therapeutics, Inc. C | 09/13/2024 | 09/24/2024 | 17.17% | 11,929,731 | 2,047,777 | 68,785 | 29.77 | |
RNAC | Cartesian Therapeutics, Inc. C | 08/30/2024 | 09/11/2024 | 16.87% | 11,924,667 | 2,012,008 | 84,759 | 23.74 | |
RNAC | Cartesian Therapeutics, Inc. C | 07/31/2024 | 08/09/2024 | 35.63% | 5,601,233 | 1,995,614 | 107,689 | 18.53 | |
RNAC | Cartesian Therapeutics, Inc. C | 07/15/2024 | 07/24/2024 | 35.65% | 5,601,233 | 1,996,754 | 371,504 | 5.37 | |
RNAC | Cartesian Therapeutics, Inc. C | 06/28/2024 | 07/10/2024 | 20.67% | 5,581,048 | 1,153,831 | 159,772 | 7.22 | |
RNAC | Cartesian Therapeutics, Inc. C | 06/14/2024 | 06/26/2024 | 40.21% | 2,017,801 | 811,442 | 90,124 | 9 | |
RNAC | Cartesian Therapeutics, Inc. C | 05/31/2024 | 06/11/2024 | 44.77% | 2,017,801 | 903,327 | 87,138 | 10.37 | |
RNAC | Cartesian Therapeutics, Inc. C | 05/15/2024 | 05/24/2024 | 47.00% | 2,017,801 | 948,355 | 87,020 | 10.9 | |
RNAC | Cartesian Therapeutics, Inc. C | 04/30/2024 | 05/09/2024 | 38.87% | 2,017,801 | 784,229 | 92,534 | 8.48 | |
RNAC | Cartesian Therapeutics, Inc. C | 04/15/2024 | 04/24/2024 | 31.65% | 2,017,801 | 638,538 | 140,384 | 4.55 | |
RNAC | Cartesian Therapeutics, Inc. C | 03/28/2024 | 04/09/2024 | 54.47% | 16,142,168 | 8,793,275 | 710,905 | 12.37 | |
RNAC | Cartesian Therapeutics, Inc. C | 03/15/2024 | 03/26/2024 | 7.36% | 112,820,073 | 8,304,750 | 889,219 | 9.34 | |
RNAC | Cartesian Therapeutics, Inc. C | 02/29/2024 | 03/11/2024 | 5.77% | 112,820,073 | 6,515,156 | 541,151 | 12.04 | |
RNAC | Cartesian Therapeutics, Inc. C | 02/15/2024 | 02/27/2024 | 5.46% | 112,799,276 | 6,163,818 | 459,811 | 13.41 | |
RNAC | Cartesian Therapeutics, Inc. C | 01/31/2024 | 02/09/2024 | 5.43% | 110,866,587 | 6,021,676 | 503,205 | 11.97 | |
RNAC | Cartesian Therapeutics, Inc. C | 01/12/2024 | 01/24/2024 | 5.16% | 110,866,587 | 5,722,569 | 820,427 | 6.98 | |
RNAC | Cartesian Therapeutics, Inc. C | 12/29/2023 | 01/10/2024 | 4.54% | 110,866,587 | 5,032,380 | 878,410 | 5.73 | |
RNAC | Cartesian Therapeutics, Inc. C | 12/15/2023 | 12/27/2023 | 4.26% | 110,866,587 | 4,721,747 | 1,273,825 | 3.71 | |
RNAC | Cartesian Therapeutics, Inc. C | 11/30/2023 | 12/11/2023 | 4.71% | 110,866,587 | 5,220,286 | 1,009,272 | 5.17 | |
RNAC | Cartesian Therapeutics, Inc. C | 11/15/2023 | 11/27/2023 | 6.85% | 110,866,587 | 7,595,047 | 892,455 | 8.51 |
In cerca di azioni più vendute allo scoperto?